Report cover image

Global Cyclosporine Drugs Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 102 Pages
SKU # APRC20354038

Description

Summary

According to APO Research, The global Cyclosporine Drugs market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Cyclosporine Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Cyclosporine Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Cyclosporine Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global companies of Cyclosporine Drugs include Takeda Pharmaceutical, Sun Pharmaceuticals Industries, Novartis, Huadong Medicine, Otsuka Pharmaceutical, Apotex, Allergan, AbbVie and United Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cyclosporine Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyclosporine Drugs.

The Cyclosporine Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cyclosporine Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Cyclosporine Drugs Segment by Company

Takeda Pharmaceutical
Sun Pharmaceuticals Industries
Novartis
Huadong Medicine
Otsuka Pharmaceutical
Apotex
Allergan
AbbVie
United Biotech
Teva Pharmaceuticals Industries
Santen Pharmaceuticals
Regenerx Biopharmaceuticals
Mckesson Medical Surgical
Mayne Pharma Group

Cyclosporine Drugs Segment by Type

Oral
Parenteral

Cyclosporine Drugs Segment by Application

Dry Eye
Rheumatoid Arthritis
Transplant Rejection Prophylaxis
Psoriasis
Autoimmune Myasthenia Gravis
Others

Cyclosporine Drugs Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclosporine Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cyclosporine Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclosporine Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2020-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Cyclosporine Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report

Table of Contents

102 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Cyclosporine Drugs Market Size Overview by Region 2020 VS 2024 VS 2031
1.4 Global Cyclosporine Drugs Market Size by Region (2020-2031)
1.4.1 Global Cyclosporine Drugs Market Size by Region (2020-2025)
1.4.2 Global Cyclosporine Drugs Market Size by Region (2026-2031)
1.5 Key Regions Cyclosporine Drugs Market Size (2020-2031)
1.5.1 North America Cyclosporine Drugs Market Size Growth Rate (2020-2031)
1.5.2 Europe Cyclosporine Drugs Market Size Growth Rate (2020-2031)
1.5.3 Asia-Pacific Cyclosporine Drugs Market Size Growth Rate (2020-2031)
1.5.4 South America Cyclosporine Drugs Market Size Growth Rate (2020-2031)
1.5.5 Middle East & Africa Cyclosporine Drugs Market Size Growth Rate (2020-2031)
2 Cyclosporine Drugs Market by Type
2.1 Type Introduction
2.1.1 Oral
2.1.2 Parenteral
2.2 Global Cyclosporine Drugs Market Size by Type
2.2.1 Global Cyclosporine Drugs Market Size Overview by Type (2020-2031)
2.2.2 Global Cyclosporine Drugs Historic Market Size Review by Type (2020-2025)
2.2.3 Global Cyclosporine Drugs Market Size Forecasted by Type (2026-2031)
2.3 Global Cyclosporine Drugs Market Size by Regions
2.3.1 North America Cyclosporine Drugs Market Size Breakdown by Type (2020-2025)
2.3.2 Europe Cyclosporine Drugs Market Size Breakdown by Type (2020-2025)
2.3.3 Asia-Pacific Cyclosporine Drugs Market Size Breakdown by Type (2020-2025)
2.3.4 South America Cyclosporine Drugs Market Size Breakdown by Type (2020-2025)
2.3.5 Middle East and Africa Cyclosporine Drugs Market Size Breakdown by Type (2020-2025)
3 Cyclosporine Drugs Market by Application
3.1 Type Introduction
3.1.1 Dry Eye
3.1.2 Rheumatoid Arthritis
3.1.3 Transplant Rejection Prophylaxis
3.1.4 Psoriasis
3.1.5 Autoimmune Myasthenia Gravis
3.1.6 Others
3.2 Global Cyclosporine Drugs Market Size by Application
3.2.1 Global Cyclosporine Drugs Market Size Overview by Application (2020-2031)
3.2.2 Global Cyclosporine Drugs Historic Market Size Review by Application (2020-2025)
3.2.3 Global Cyclosporine Drugs Market Size Forecasted by Application (2026-2031)
3.3 Global Cyclosporine Drugs Market Size by Regions
3.3.1 North America Cyclosporine Drugs Market Size Breakdown by Application (2020-2025)
3.3.2 Europe Cyclosporine Drugs Market Size Breakdown by Application (2020-2025)
3.3.3 Asia-Pacific Cyclosporine Drugs Market Size Breakdown by Application (2020-2025)
3.3.4 South America Cyclosporine Drugs Market Size Breakdown by Application (2020-2025)
3.3.5 Middle East and Africa Cyclosporine Drugs Market Size Breakdown by Application (2020-2025)
4 Global Market Dynamics
4.1 Cyclosporine Drugs Industry Trends
4.2 Cyclosporine Drugs Industry Drivers
4.3 Cyclosporine Drugs Industry Opportunities and Challenges
4.4 Cyclosporine Drugs Industry Restraints
5 Competitive Insights by Company
5.1 Global Top Players by Cyclosporine Drugs Revenue (2020-2025)
5.2 Global Cyclosporine Drugs Industry Company Ranking, 2023 VS 2024 VS 2025
5.3 Global Cyclosporine Drugs Key Company Headquarters & Area Served
5.4 Global Cyclosporine Drugs Company, Product Type & Application
5.5 Global Cyclosporine Drugs Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Cyclosporine Drugs Market CR5 and HHI
5.6.2 Global Top 5 and 10 Cyclosporine Drugs Players Market Share by Revenue in 2024
5.6.3 2024 Cyclosporine Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
6.1 Takeda Pharmaceutical
6.1.1 Takeda Pharmaceutical Comapny Information
6.1.2 Takeda Pharmaceutical Business Overview
6.1.3 Takeda Pharmaceutical Cyclosporine Drugs Revenue, Global Share and Gross Margin (2020-2025)
6.1.4 Takeda Pharmaceutical Cyclosporine Drugs Product Portfolio
6.1.5 Takeda Pharmaceutical Recent Developments
6.2 Sun Pharmaceuticals Industries
6.2.1 Sun Pharmaceuticals Industries Comapny Information
6.2.2 Sun Pharmaceuticals Industries Business Overview
6.2.3 Sun Pharmaceuticals Industries Cyclosporine Drugs Revenue, Global Share and Gross Margin (2020-2025)
6.2.4 Sun Pharmaceuticals Industries Cyclosporine Drugs Product Portfolio
6.2.5 Sun Pharmaceuticals Industries Recent Developments
6.3 Novartis
6.3.1 Novartis Comapny Information
6.3.2 Novartis Business Overview
6.3.3 Novartis Cyclosporine Drugs Revenue, Global Share and Gross Margin (2020-2025)
6.3.4 Novartis Cyclosporine Drugs Product Portfolio
6.3.5 Novartis Recent Developments
6.4 Huadong Medicine
6.4.1 Huadong Medicine Comapny Information
6.4.2 Huadong Medicine Business Overview
6.4.3 Huadong Medicine Cyclosporine Drugs Revenue, Global Share and Gross Margin (2020-2025)
6.4.4 Huadong Medicine Cyclosporine Drugs Product Portfolio
6.4.5 Huadong Medicine Recent Developments
6.5 Otsuka Pharmaceutical
6.5.1 Otsuka Pharmaceutical Comapny Information
6.5.2 Otsuka Pharmaceutical Business Overview
6.5.3 Otsuka Pharmaceutical Cyclosporine Drugs Revenue, Global Share and Gross Margin (2020-2025)
6.5.4 Otsuka Pharmaceutical Cyclosporine Drugs Product Portfolio
6.5.5 Otsuka Pharmaceutical Recent Developments
6.6 Apotex
6.6.1 Apotex Comapny Information
6.6.2 Apotex Business Overview
6.6.3 Apotex Cyclosporine Drugs Revenue, Global Share and Gross Margin (2020-2025)
6.6.4 Apotex Cyclosporine Drugs Product Portfolio
6.6.5 Apotex Recent Developments
6.7 Allergan
6.7.1 Allergan Comapny Information
6.7.2 Allergan Business Overview
6.7.3 Allergan Cyclosporine Drugs Revenue, Global Share and Gross Margin (2020-2025)
6.7.4 Allergan Cyclosporine Drugs Product Portfolio
6.7.5 Allergan Recent Developments
6.8 AbbVie
6.8.1 AbbVie Comapny Information
6.8.2 AbbVie Business Overview
6.8.3 AbbVie Cyclosporine Drugs Revenue, Global Share and Gross Margin (2020-2025)
6.8.4 AbbVie Cyclosporine Drugs Product Portfolio
6.8.5 AbbVie Recent Developments
6.9 United Biotech
6.9.1 United Biotech Comapny Information
6.9.2 United Biotech Business Overview
6.9.3 United Biotech Cyclosporine Drugs Revenue, Global Share and Gross Margin (2020-2025)
6.9.4 United Biotech Cyclosporine Drugs Product Portfolio
6.9.5 United Biotech Recent Developments
6.10 Teva Pharmaceuticals Industries
6.10.1 Teva Pharmaceuticals Industries Comapny Information
6.10.2 Teva Pharmaceuticals Industries Business Overview
6.10.3 Teva Pharmaceuticals Industries Cyclosporine Drugs Revenue, Global Share and Gross Margin (2020-2025)
6.10.4 Teva Pharmaceuticals Industries Cyclosporine Drugs Product Portfolio
6.10.5 Teva Pharmaceuticals Industries Recent Developments
6.11 Santen Pharmaceuticals
6.11.1 Santen Pharmaceuticals Comapny Information
6.11.2 Santen Pharmaceuticals Business Overview
6.11.3 Santen Pharmaceuticals Cyclosporine Drugs Revenue, Global Share and Gross Margin (2020-2025)
6.11.4 Santen Pharmaceuticals Cyclosporine Drugs Product Portfolio
6.11.5 Santen Pharmaceuticals Recent Developments
6.12 Regenerx Biopharmaceuticals
6.12.1 Regenerx Biopharmaceuticals Comapny Information
6.12.2 Regenerx Biopharmaceuticals Business Overview
6.12.3 Regenerx Biopharmaceuticals Cyclosporine Drugs Revenue, Global Share and Gross Margin (2020-2025)
6.12.4 Regenerx Biopharmaceuticals Cyclosporine Drugs Product Portfolio
6.12.5 Regenerx Biopharmaceuticals Recent Developments
6.13 Mckesson Medical Surgical
6.13.1 Mckesson Medical Surgical Comapny Information
6.13.2 Mckesson Medical Surgical Business Overview
6.13.3 Mckesson Medical Surgical Cyclosporine Drugs Revenue, Global Share and Gross Margin (2020-2025)
6.13.4 Mckesson Medical Surgical Cyclosporine Drugs Product Portfolio
6.13.5 Mckesson Medical Surgical Recent Developments
6.14 Mayne Pharma Group
6.14.1 Mayne Pharma Group Comapny Information
6.14.2 Mayne Pharma Group Business Overview
6.14.3 Mayne Pharma Group Cyclosporine Drugs Revenue, Global Share and Gross Margin (2020-2025)
6.14.4 Mayne Pharma Group Cyclosporine Drugs Product Portfolio
6.14.5 Mayne Pharma Group Recent Developments
7 North America
7.1 North America Cyclosporine Drugs Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2 North America Cyclosporine Drugs Market Size by Country (2020-2025)
7.3 North America Cyclosporine Drugs Market Size Forecast by Country (2026-2031)
8 Europe
8.1 Europe Cyclosporine Drugs Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2 Europe Cyclosporine Drugs Market Size by Country (2020-2025)
8.3 Europe Cyclosporine Drugs Market Size Forecast by Country (2026-2031)
9 Asia-Pacific
9.1 Asia-Pacific Cyclosporine Drugs Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2 Asia-Pacific Cyclosporine Drugs Market Size by Country (2020-2025)
9.3 Asia-Pacific Cyclosporine Drugs Market Size Forecast by Country (2026-2031)
10 South America
10.1 South America Cyclosporine Drugs Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2 South America Cyclosporine Drugs Market Size by Country (2020-2025)
10.3 South America Cyclosporine Drugs Market Size Forecast by Country (2026-2031)
11 Middle East & Africa
11.1 Middle East & Africa Cyclosporine Drugs Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2 Middle East & Africa Cyclosporine Drugs Market Size by Country (2020-2025)
11.3 Middle East & Africa Cyclosporine Drugs Market Size Forecast by Country (2026-2031)
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.